Agneta Zickert

2.7k total citations
56 papers, 2.0k citations indexed

About

Agneta Zickert is a scholar working on Rheumatology, Immunology and Nephrology. According to data from OpenAlex, Agneta Zickert has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Rheumatology, 34 papers in Immunology and 14 papers in Nephrology. Recurrent topics in Agneta Zickert's work include Systemic Lupus Erythematosus Research (52 papers), Renal Diseases and Glomerulopathies (14 papers) and T-cell and B-cell Immunology (14 papers). Agneta Zickert is often cited by papers focused on Systemic Lupus Erythematosus Research (52 papers), Renal Diseases and Glomerulopathies (14 papers) and T-cell and B-cell Immunology (14 papers). Agneta Zickert collaborates with scholars based in Sweden, United States and France. Agneta Zickert's co-authors include Iva Gunnarsson, Elisabet Svenungsson, Birgitta Sundelin, Ioannis Parodis, Vilija Oke, Vivianne Malmström, Johan Rönnelid, Johanna Gustafsson, Susanna Eketjäll and Andreas Jönsen and has published in prestigious journals such as The Lancet, PLoS ONE and Scientific Reports.

In The Last Decade

Agneta Zickert

55 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agneta Zickert Sweden 28 1.6k 1.2k 389 363 239 56 2.0k
Josefina Cortés-Hernández Spain 26 1.2k 0.7× 1.2k 1.0× 346 0.9× 317 0.9× 267 1.1× 60 2.4k
Romeo Maciuca United States 13 1.6k 1.0× 1.3k 1.1× 358 0.9× 753 2.1× 90 0.4× 29 2.5k
Dana Tegzová Czechia 15 1.7k 1.1× 1.0k 0.9× 166 0.4× 657 1.8× 341 1.4× 22 2.1k
Paz Lavilla Spain 7 1.9k 1.2× 1.0k 0.9× 311 0.8× 433 1.2× 287 1.2× 8 2.1k
Lilia Pineda United States 11 2.3k 1.5× 1.8k 1.6× 207 0.5× 1.1k 3.1× 170 0.7× 17 3.0k
Douglas R. Hough United States 12 1.8k 1.1× 1.5k 1.3× 131 0.3× 859 2.4× 269 1.1× 16 2.4k
Renato Guzmán United States 5 1.4k 0.9× 1.1k 1.0× 174 0.4× 767 2.1× 108 0.5× 10 1.8k
Ana Malvar Argentina 16 1.3k 0.8× 753 0.6× 713 1.8× 397 1.1× 69 0.3× 45 1.6k
AO. Aydintug Türkiye 7 1.9k 1.2× 1.0k 0.9× 302 0.8× 436 1.2× 246 1.0× 11 2.2k
Omid Zamani United States 6 1.5k 0.9× 1.3k 1.1× 82 0.2× 641 1.8× 261 1.1× 12 2.1k

Countries citing papers authored by Agneta Zickert

Since Specialization
Citations

This map shows the geographic impact of Agneta Zickert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta Zickert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta Zickert more than expected).

Fields of papers citing papers by Agneta Zickert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agneta Zickert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta Zickert. The network helps show where Agneta Zickert may publish in the future.

Co-authorship network of co-authors of Agneta Zickert

This figure shows the co-authorship network connecting the top 25 collaborators of Agneta Zickert. A scholar is included among the top collaborators of Agneta Zickert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agneta Zickert. Agneta Zickert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zickert, Agneta, et al.. (2023). Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort study. Clinical Rheumatology. 42(11). 2981–2986. 1 indexed citations
2.
Díaz-Gallo, Lina-Marcela, Vilija Oke, Emeli Lundström, et al.. (2021). Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA‐DRB1 Genotype Associations and Immunological and Clinical Manifestations. ACR Open Rheumatology. 4(1). 27–39. 28 indexed citations
3.
Sohrabian, Azita, Ioannis Parodis, Martina Frodlund, et al.. (2019). Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 21(1). 259–259. 16 indexed citations
4.
Kvarnström, Marika, Agneta Zickert, Vilija Oke, et al.. (2019). Sjögren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State. The Journal of Rheumatology. 47(6). 865–875. 28 indexed citations
5.
Oke, Vilija, Iva Gunnarsson, Jessica M. Dorschner, et al.. (2019). High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus. Arthritis Research & Therapy. 21(1). 107–107. 147 indexed citations
6.
Parodis, Ioannis, Huihua Ding, Agneta Zickert, et al.. (2019). Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis. PLoS ONE. 14(2). e0212068–e0212068. 16 indexed citations
7.
Wigren, Maria, Elisabet Svenungsson, Ingrid Yao Mattisson, et al.. (2018). Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis. Atherosclerosis. 270. 1–7. 26 indexed citations
8.
Parodis, Ioannis, Christopher Sjöwall, Andreas Jönsen, et al.. (2017). Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus. Autoimmunity Reviews. 16(4). 343–351. 84 indexed citations
9.
Svenungsson, Elisabet, Andreas Jönsen, Dag Leonard, et al.. (2017). 237 Ischaemic stroke in systemic lupus erythematosus, -distribution of subtypes and a risk genotype in the stat4 gene. A108.3–A109.
10.
Oke, Vilija, Susanna Brauner, Anders Larsson, et al.. (2017). IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE). Arthritis Research & Therapy. 19(1). 139–139. 49 indexed citations
11.
Parodis, Ioannis, Laurent Arnaud, Agneta Zickert, et al.. (2016). Antiphospholipid Antibodies in Lupus Nephritis. PLoS ONE. 11(6). e0158076–e0158076. 28 indexed citations
12.
Jönsen, Andreas, Frida Hjalte, Katarina Steen Carlsson, et al.. (2015). Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts. Seminars in Arthritis and Rheumatism. 45(6). 684–690. 26 indexed citations
13.
Zickert, Agneta, Petra Amoudruz, Yvonne Sundström, et al.. (2015). IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment. BMC Immunology. 16(1). 7–7. 114 indexed citations
14.
Gustafsson, Johanna, Iva Gunnarsson, Henrik Källberg, et al.. (2014). Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases. 74(8). 1537–1543. 62 indexed citations
15.
Bolin, Karin, Johanna K. Sandling, Agneta Zickert, et al.. (2013). Association of STAT4 Polymorphism with Severe Renal Insufficiency in Lupus Nephritis. PLoS ONE. 8(12). e84450–e84450. 83 indexed citations
16.
Gustafsson, Johanna, Andreas Jönsen, Dag Leonard, et al.. (2012). Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays. Lara D. Veeken. 52(3). 501–509. 44 indexed citations
17.
Lundström, Emeli, Johanna Gustafsson, Andreas Jönsen, et al.. (2012). HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 72(6). 1018–1025. 48 indexed citations
18.
Jönsen, Andreas, Sara C. Nilsson, Emma Ahlqvist, et al.. (2011). Mutations in genes encoding complement inhibitors CD46 and CFHaffect the age at nephritis onset in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 13(6). R206–R206. 26 indexed citations
19.
20.
Sjöwall, Christopher, Agneta Zickert, Thomas Skogh, Jonas Wetterö, & Iva Gunnarsson. (2009). Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis. Arthritis Research & Therapy. 11(6). R188–R188. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josefina Cortés-Hernández Breakdown of academic impact, for papers by Romeo Maciuca Breakdown of academic impact, for papers by Dana Tegzová Breakdown of academic impact, for papers by Paz Lavilla Breakdown of academic impact, for papers by Lilia Pineda Breakdown of academic impact, for papers by Douglas R. Hough Breakdown of academic impact, for papers by Renato Guzmán Breakdown of academic impact, for papers by Ana Malvar Breakdown of academic impact, for papers by AO. Aydintug Breakdown of academic impact, for papers by Omid Zamani
Rankless by CCL
2026